Region:Middle East
Product Code:KR475
The report titled "Qatar Healthcare Market to 2021 - High Prevalence of Diabetes and Rising Healthcare Infrastructure to Foster Future Growth" provides a comprehensive analysis of the healthcare market in Qatar. The report focuses on the hospitals and clinics, medical devices used in the hospital setting, diagnostic laboratories, clinics and polyclinics, pharmaceutical drugs and injectable used for treatment and diagnostic purposes, and services provided by healthcare providers. The report covers aspects such as overall healthcare market by its key segments including medical devices, pharmaceuticals, hospitals, independent diagnostic laboratories, clinics/polyclinics, retail pharmacy and their sub-segments. The publication also includes the competitive landscape in each section, which discusses the major market players in every segment along with the detailed discussion about the organization. The future analysis of overall Qatar Healthcare has also been discussed along with recommendations from analyst view. The report also includes information about health insurance in Qatar, regulatory bodies governing healthcare policies in Qatar, regulations which impact healthcare market and procedure to import medical devices and pharmaceuticals in the country.
Market Potential
Qatar healthcare market is one of the fastest growing markets in the world with the growth rate of ~% during the period 2011-2016. People across Qatar are facing several health care issues due to sedentary lifestyle and fast food consumption habits, such as obesity, diabetes, and other cardiovascular diseases, which are demanding for technologically advanced healthcare infrastructure. Qatar has been exponentially expanding its national healthcare system to cater the needs of its people and support economic diversification. The country has been developing its infrastructure including hospitals, diagnostic labs, and clinics in addition to the development of local clinicians, physicians and specialized doctors. In addition to all these factors, fast rising and ageing population in the country further add to the advantages for Qatar healthcare market.
Medical Devices Market: Qatar is an import driven market in context to medical devices. The imports of medical devices accounted for a lion share of ~% from the total revenue market in 2016. The market is observed to grow at a rapid pace of ~% by value from 2011 to 2016 owing to the expanding healthcare infrastructure in the country; both the government and private healthcare sector are investing heavily to provide country satisfactory healthcare solutions to the residents and expats. Diagnostic imaging products were observed to capture the major share of the market (~% in 2016), however Scintigraphic apparatus and Magnetic resonance imaging apparatus recorded the highest growth in 2016. Qatar having one of the highest GDP per capita, the healthcare professionals and citizens across the nation prefer the branded medical devices from Roche, Abbott, Biomeriux, Becton Dickinson, providing all of them leading position in the market. The top three players together captured around ~% of the total revenue share in 2016.
Pharmaceuticals Market: Pharmaceuticals market is highly dependent upon imports of pharmaceutical products. Imports accounted for ~% of the total revenue in 2016 for pharmaceuticals market in Qatar. The rising prevalence of chronic diseases among the fast growing population of Qatar was the major factor responsible for the growth of the pharmaceutical products market in Qatar at rapid rate. Patented drugs were observed to be preferred more than generic drugs and captured a revenue share of ~% in 2016. Qatar Pharma is the major domestic player which is manufacturing drugs for the Qatar pharmaceuticals market. Drugs were imported from a plethora of companies including Roche, MSD (Merck), GSK, Novartis, Sanofi, AstraZeneca and others. The top three players together captured a market share of ~% as of 2016. Among prescribed and OTC drugs, prescribed drugs accounted for ~% of the market share. In context to therapeutic area, high prevalence of diabetes in the region has led to demand for diabetes management pharmaceutical products providing it dominance over other therapeutic class with share of ~% in 2016.
Hospitals Market: Hospitals market in Qatar has experienced rapid increase in number of inpatients and outpatients from 2011 to 2016. Although the number of hospitals has been constant for the last few years, number of inpatients and outpatients increased at a CAGR of ~% and ~% respectively during 2011-2016. Contribution from pharmacy store increased to a high extent owing to the increased sales of medical devices and cosmetic products from hospital based pharmacies, generating high revenue. Private hospitals were observed to be major revenue generator with ~% of revenue share in 2016. HMC was the largest provider of healthcare services in the country.
Independent Diagnostic Laboratories Market: Independent diagnostic laboratories is most recently established market in Qatar with revenue of USD ~ million in 2016 and exhibiting growth at a CAGR of ~% during the period 2011-2016. The rising self care attitude among people coupled with increasing prevalence of chronic diseases was the major factor which has led to growth of independent diagnostic laboratories. These laboratories are actively engaged in providing pathology tests, and pathology tests contributed approximately ~% of the total revenue in 2016. Radiology tests generated comparatively lower share of the market majorly due to presence of limited number of radiology services including X-ray and ultrasound and higher prescription of pathology tests over radiology tests.
Key Topics Covered in the Report:
Diagnostic Imaging Products, Medical Consumables, Dental Products, Assistive Devices, Orthopedic and Implants, Generic Drugs, Patented Drugs, OTC Drugs
Roche, Abbott, Biomeriux, Becton Dickinson, Beckman Coulter, Merck (MSD), GSK, Sanofi, Novartis, AstraZeneca, Qatar Pharma, Qatari German Medical Equipments
1. Executive Summary
Market Potential
Market Segmentation
Medical Devices Market
Pharmaceuticals Market
Pharmacy Retail Market
Hospitals Market
Independent Diagnostic Laboratories Market
Clinics/Health Centers Market
2. Research Methodology
2.1. Market Definitions
2.2. Abbreviations
2.3. Market Size and Modeling
Approach - Market Sizing
Market Sizing - Overall Healthcare Market
Market Sizing - Medical Devices and Pharmaceuticals Market and Retail Pharmacy
Market Sizing - Hospitals Market
Market Sizing -Independent Diagnostic Laboratories Market
Variables (Dependent and Independent)
Multi Factor Based Sensitivity Model
Limitations
Final Conclusion
3. Qatar Healthcare Sector Introduction and Private Spending, 2011-2021
4. Qatar Medical Devices Market Size by Value, CY2011 -CY2016
4.1. Qatar Medical Devices Market Segmentation, CY2011 - CY2016
4.1.1. By Application (Diagnostic Imaging Products, Medical Consumables, Dental Products, Assistive Devices, Orthopedic and Implants and Others), CY2016
4.1.2. By Institutional and Household Demand, CY2011-CY2016
4.1.3. By Domestic Demand and Imports, CY2011 - CY2016
4.2. Imports of Medical Devices in Qatar
4.2.1. Import Duties
4.2.2. Segmentation of Imported Medical Devices in Qatar, CY2011 - CY2016
By Type of Products, CY2011 - CY2016
4.3. Regulatory Environment for Medical Devices in Qatar
4.4. Company Profiles for Major Players in Qatar Medical Devices Market
Roche
Abbott
Biomeriux
Becton Dickinson
Beckman Coulter
4.5. Market Share of Major Market Players in Qatar Medical Devices Market, CY2016
4.6. Decision Making Process to Shortlist Medical Device
4.7. Qatar Medical Devices Market Future Outlook and Projections, CY2017 - CY2021
5. Qatar Pharmaceuticals Market Size by Value, CY2011-CY2016
5.1. Qatar Pharmaceuticals Market Segmentation
5.1.1. By Generic and Patented Drugs, CY2011-CY2016
5.1.2. By OTC and Prescribed Drugs, CY2011 - CY2016
5.1.3. By Domestic Demand and Imports, CY2011 - CY2016
5.1.4. By Therapeutic Area, CY2016
5.2. Imports of Pharmaceuticals in Qatar
5.2.1. Import Duties
5.2.2. Segmentation of Imported Medical Devices in Qatar, CY2011 - CY2016
By Type of Products, CY2011 - CY2016
5.3. Qatar Pharmaceuticals Competitive Landscape
5.3.1. Company Profiles of Major Players in Qatar Pharmaceuticals Market
Roche
Merck (MSD)
GSK
Novartis
Sanofi
AstraZeneca
5.4. Market Share of Major Players in Qatar Pharmaceuticals Market
5.5. Qatar Pharmaceuticals Future Outlook and Projections, CY2017-CY2021
6. Qatar Retail Pharmacy Market Size, CY2011-CY2016
6.1. Qatar Retail Pharmacy Market Segmentation
6.1.1. By Type of Pharmacy (Stand-alone and Hospital Based), CY2016
6.2. Qatar Retail Pharmacy Future Outlook and Projections, CY2017-CY2021
7. Qatar Hospital Market Size
7.1. By Revenue, CY2011 - CY2016
7.2. By Number of Hospitals, CY2011 - CY2016
7.3. By Number of Beds, CY2011 - CY2016
7.4. Qatar Hospital Market Segmentation
7.4.1. By Public and Private Hospitals, CY2011 - CY2016
7.5. Qatar Hospital Market Competitive Landscape
7.5.1. Hospital Profiles
Hamad Medical Corporation
Al Ahli Hospital
American Hospital
Aspetar Hospital
Doha Clinic Hospital
Al Emadi Hospital
7.6. Qatar Hospital Market Future Outlook and Projections, CY2017-CY2021
8. Qatar Clinic and Health Center Market Size, CY2011-CY2016
8.1. Qatar Clinic and Health Center Market Segmentation
8.1.1. By Revenue Streams (Outpatient, Diagnostic Labs and Pharmacy), CY2016
8.1.2. By Type of Clinic (Private and Public), CY2016
8.2. Qatar Clinic and Health Center Market Future Outlook and Projections, CY2017-CY2021
9. Qatar Independent Diagnostic Laboratories Market Size, CY2011-CY2016
9.1. Qatar Independent Diagnostic Laboratories Market Segmentation
9.1.1. By Type of Tests (Pathological and Radiological), CY2016
9.2. Competitive Landscape of Major Players
9.3. Qatar Independent Diagnostic Laboratories Market Future Outlook and Projection, CY2017-CY2021
10. Snapshot on Qatar Telemedicine Market
11. Analyst Recommendations
12. Macro Economic Factors Impacting Qatar Healthcare Market
12.1. Per Capita Healthcare Spending in Qatar
12.2. Government Expenditure on Healthcare
12.3. Diabetic Population of Qatar
Disclaimer
Contact Us
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.